Advertisement
Research Article

Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation

  • Sydney X. Lu,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Lucy W. Kappel equal contributor,

    equal contributor Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Immunology, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America

    X
  • Anne-Marie Charbonneau-Allard equal contributor,

    equal contributor Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah

    Affiliation: Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada

    X
  • Renée Atallah equal contributor,

    equal contributor Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah

    Affiliation: Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada

    X
  • Amanda M. Holland,

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Immunology, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America

    X
  • Claire Turbide,

    Affiliation: Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada

    X
  • Vanessa M. Hubbard,

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States of America

    X
  • Jimmy A. Rotolo,

    Affiliation: Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Marsinay Smith,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • David Suh,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Christopher King,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Uttam K. Rao,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Nury Yim,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Johanne L. Bautista,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Robert R. Jenq,

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Olaf Penack,

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Hematology and Oncology, Charité CBF - Universitätsmedizin Berlin, Berlin, Germany

    X
  • Il-Kang Na,

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Hematology and Oncology, Charité CBF - Universitätsmedizin Berlin, Berlin, Germany

    X
  • Chen Liu,

    Affiliation: Department of Pathology, University of Florida College of Medicine, Gainesville, Florida, United States of America

    X
  • George Murphy,

    Affiliation: Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Onder Alpdogan,

    Affiliations: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Medicine, Yale University Medical School, New Haven, Connecticut, United States of America

    X
  • Richard S. Blumberg,

    Affiliation: Department of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

    X
  • Fernando Macian,

    Affiliation: Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States of America

    X
  • Kathryn V. Holmes,

    Affiliation: Department of Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America

    X
  • Nicole Beauchemin ,

    Affiliation: Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada

    These authors also contributed equally to this work.

    X
  • Marcel R. M. van den Brink

    Affiliation: Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    These authors also contributed equally to this work.

    X
  • Published: July 06, 2011
  • DOI: 10.1371/journal.pone.0021611

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.